Publication:
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease

Simple item page
dc.contributor.affiliation000000041762408X
dc.contributor.affiliation"Department for Life Quality Studies, Alma Mater Studiorum-University of Bologna, Corso d’Augusto 237, Rimini, 47921, Italy"," Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, Torino, 10125, Italy"," Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Via Belmeloro 8, Bologna, 40126, Italy"," Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, Via Belmeloro 6, Bologna, 40126, Italy"," Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA-Nanociencia), C/Faraday 9, Madrid, 28049, Spain"," Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, Madrid, 28029, Spain"en
dc.contributor.authorGuardigni M.
dc.contributor.authorPruccoli L.
dc.contributor.authorSantini A.
dc.contributor.authorSimone A.D.
dc.contributor.authorBersani M.
dc.contributor.authorSpyrakis F.
dc.contributor.authorFrabetti F.
dc.contributor.authorUliassi E.
dc.contributor.authorAndrisano V.
dc.contributor.authorPagliarani B.
dc.contributor.authorFernández-Gómez P.
dc.contributor.authorPalomo, Valle
dc.contributor.authorBolognesi M.L.
dc.contributor.authorTarozzi A.
dc.contributor.authorMilelli A.
dc.date.accessioned2023-07-31T14:18:54Z
dc.date.available2023-07-31T14:18:54Z
dc.date.issued2023
dc.format.mimetypeapplication/pdf
dc.identifier.doi10.1021/acschemneuro.3c00096
dc.identifier.urihttp://hdl.handle.net/20.500.12614/3394
dc.journal.titleACS Chemical Neuroscience
dc.language.isoen
dc.page.initial1963
dc.relation.projectIDTEMPThis work is dedicated to Prof. Carlo Melchiorre, on the occasion of his 80th birthday. This research was supported by the University of Bologna (Grant RFO), University of Turin (SPY_RILO_20_01, SPY_RILO_21_01), and partially by MIUR-FISR2019_03796 “Proteolysis targeting chimeras (PROTACs) to treat leishmaniasis”- PROLEISH.
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.titlePROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number14
dspace.entity.typePublication
relation.isAuthorOfPublication8585ec30-1068-4aa7-8bed-3ab740eb7123
relation.isAuthorOfPublication.latestForDiscovery8585ec30-1068-4aa7-8bed-3ab740eb7123

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Dise.pdf
Size:
3.74 MB
Format:
Adobe Portable Document Format
Download

Collections

Publications